Intraperitoneal Chemotherapy in Advanced Ovarian Cancer Improves Survival, But Is Underused



Use of intraperitoneal chemotherapy, along with intravenous chemotherapy, improves survival in some women with advanced ovarian cancer, but its use in clinical practice has been limited, according to a new study.



Source link

Comments are closed.